Management Of Early Rubeosis Iridis In Diabetic Patients Using Triamcinolone Acetonide
|Full paper||Not Available|
Purpose: To determine the effict of intracameral injection of Triamcinolone Acetonide (Kenacort-A 40mg/m1) in cases of early rubeosis iridis in diabetic patients and the effect of intracameral injection of Triamcinolone Acetonide (Kenacort-A 40mg/m1) on corneal endothelium and trabecular meshwork of rabbits. Methods: Fifteen eyes of diabetic patients. Six patients with bilateral rubeosis and three patients with rubeosis in on eye were included in this study. Under local anaesthesia and aseptic condition, Triamcinolone Acetonide 0.2ml (8mg/m1) was injected intracameral. Followed up for 6 months. Ten adult rabbits (average weight 1.5-2.25kg) with apparently healthy eyes were used; three rabbits served as control group (injected with BSS) and seven rabbits served as treated group, injected with Triamcinolone Acetonide 40ntg/m1 in a dose of 0.2ml was injected intracameral.